4SCAR-CD44v6 T cell therapy

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4SCAR-CD44v6 T cell therapy, covering 2020-06-11 to 2020-06-11. Get the full timeline:

Most recent: Clinical Trial Update: 4SCAR-CD44v6 T Cell Therapy Targeting Cancer [Phase 1, Phase 2]